HuGE Literature Finder
Records
1
-
11
| Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR). Acta cardiologica 2022 10 77 (9): 836-845. Kis Mehmet, Dogan Yasemin, Yildirim Abdullah, Güzel Tuncay, Bekar Lutfu, Akhan Onur, Dogdus Mustafa, Harbal?o?lu Hazar, Karabulut Dilay, Soydan Elton, Zoghi Mehdi, Ergene Oktay, |
| High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME). Journal of clinical medicine 2021 May 10 (10): . Fan Yiting, Chan Tsz-Ngai, Chow Josie T Y, Kam Kevin K H, Chi Wai-Kin, Chan Joseph Y S, Fung Erik, Tong Mabel M P, Wong Jeffery K T, Choi Paul C L, Chan David K H, Sheng Bun, Lee Alex Pui-W |
| Characterization of dynamic changes in Matrix Gla Protein (MGP) gene expression as function of genetic risk alleles, osteoarthritis relevant stimuli, and the vitamin K inhibitor warfarin. Osteoarthritis and cartilage 2021 5 29 (8): 1193-1202. Houtman E, Coutinho de Almeida R, Tuerlings M, Suchiman H E D, Broekhuis D, Nelissen R G H H, Ramos Y F M, van Meurs J B J, Meulenbelt |
| Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy. The American journal of the medical sciences 2021 7 362 (3): 260-267. Xiao Yan, Sun Yang, Tian Tao, Wang Tian-Jie, Zhao Ran-Xu, Zhang Ying, Wang Lin-Ping, Liu Ya-Xin, Lu Chao-Xia, Zhou Xian-Liang, Yang Wei-Xi |
| Cardiomyopathy associated with the Ala143Thr variant of the ?-galactosidase A gene. Heart (British Cardiac Society) 2020 1 106 (8): 609-615. Valtola Kati, Nino-Quintero Juanita, Hedman Marja, Lottonen-Raikaslehto Line, Laitinen Tomi, Maria Maleeha, Kantola Ilkka, Naukkarinen Anita, Laakso Markku, Kuusisto Johan |
| Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy. PloS one 2020 9 15 (9): e0239675. Sadasivan Chandu, Chow Josie T Y, Sheng Bun, Chan David K H, Fan Yiting, Choi Paul C L, Wong Jeffrey K T, Tong Mabel M B, Chan Tsz-Ngai, Fung Erik, Kam Kevin K H, Chan Joseph Y S, Chi Wai-Kin, Paterson D Ian, Senaratne Manohara, Brass Neil, Oudit Gavin Y, Lee Alex P |
| Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. International journal of cardiology 2019 8 300 191-195. Maurizi Niccolò, Rella Valeria, Fumagalli Carlo, Salerno Sabrina, Castelletti Silvia, Dagradi Federica, Torchio Margherita, Marceca Azzurra, Meda Martino, Gasparini Massimo, Boschi Beatrice, Girolami Francesca, Parati Gianfranco, Olivotto Iacopo, Crotti Lia, Cecchi Fran |
| Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy. Journal of Korean medical science 2019 2 34 (7): e63. Kim Woo-Shik, Kim Hyun Soo, Shin Jinho, Park Jong Chun, Yoo Han-Wook, Takenaka Toshihiro, Tei Chu |
| Awareness of Fabry disease in cardiology: A gap to be filled. Revista portuguesa de cardiologia 2018 5 37 (6): 457-466. Brito Dulce, Cardim Nuno, Lopes Luís Rocha, Belo Adriana, Mimoso Jorge, Gonçalves Lino, Madeira Hugo, |
| Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation. PloS one 2018 4 13 (4): e0193550. Lavalle L, Thomas A S, Beaton B, Ebrahim H, Reed M, Ramaswami U, Elliott P, Mehta A B, Hughes D |
| Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circulation. Cardiovascular genetics 2011 Jun 4 (3): 288-95. Gruner Christiane, Care Melanie, Siminovitch Katherine, Moravsky Gil, Wigle E Douglas, Woo Anna, Rakowski Har |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: